CardioDx strikes deal to bring artery disease assay to India

04/26/2013 | GenomeWeb Daily News (free registration)

CardioDx has agreed to allow Core Diagnostics India to distribute its Corus CAD diagnostic system in India for undisclosed terms. The blood-based gene expression test, which was released as a laboratory-developed assay in 2009, is intended to screen patients showing symptoms of obstructive coronary artery disease.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC